Funding Details
- Date Award
- May 13, 2024
- Vertical
- Therapeutics
- Funding URL
- View Funding Page
Company Info
- Traction
- None
- Organizations Involved
- None
- Founders
- Ksenia Burka, Giorgio Fracasso
- Company Description
- Reactosome is a synthetic cell platform that enables an efficient new class of nucleic acid therapies, unlocking treatments for complex diseases like solid cancers and age-related disorders by affecting 10x more genes than traditional methods
- Location
-
Germany
- Coinvestors
- None
Links